Synthesis and anticancer evaluation of certain γ-aryloxymethyl-α- methylene-γ-phenyl-γ-butyrolactones

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 19, 1998, Pages 2773-2776

  Wang, Tai Chi ^a,b   Lee, Kuan Han ^b   Chen, Yeh Long ^a   Liou, Shorong Shii ^b   Tzeng, Cherng Chyi ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 METHYLQUINOLINEOXYMETHYL ALPHA METHYLENE GAMMA PHENYL GAMMA BUTYROLACTONE; ALPHA 8 HYDROXYQUINOLINEOXYMETHYL ALPHA METHYLENE GAMMA PHENYL GAMMA BUTYROLACTONE; ALPHA BENZENEOXYMETHYL ALPHA METHYLENE GAMMA PHENYL GAMMA BUTYROLACTONE; ALPHA NAPHTHALENEOXYMETHYL ALPHA METHYLENE GAMMA PHENYL GAMMA BUTYROLACTONE; ALPHA QUINOLINEOXYMETHYL ALPHA METHYLENE GAMMA PHENYL GAMMA BUTYROLACTONE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; DRUG CONFORMATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CANCER; MELANOMA; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

EID: 0032491235     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00487-9     Document Type: Article

References (22)

1. 1. Lee, K. H.; Hall, I. H.; Mar, E. C.; Starnes, C. O.; Elgebaly, S. A.; Waddell, T. G.; Hadgraft, R. I.; Ruffner, C. G.; Weidner, I. Science 1977, 196, 533-535.
2. 2. Spring, O.; Albert, K.; Gradmann, W. Phytochemistry 1981, 20, 1883-1885.
3. 3. Hoffmann, H. M. R.; Rabe, J. Angew. Chem. Int. Ed. Engl. 1985, 24, 94-110.
4. 4. Park, B. K.; Nakagawa, M.; Hirota, A.; Nakayama, M. J. Antibiot. 1988, 41, 751-758.
5. 5. Zhu, G.; Lu, X. J. Org. Chem. 1995, 60, 1087-1089.
6. 6. Maiti, G.; Roy, C. J. Chem. Soc., Perkin Trans. 1 1996, 403-404.
7. 7. Kupchan, S. M.; Fessler, D. C.; Eakin, M. A.; Giacobbe, T. J. Science 1970, 168: 376-378.
8. 8. Petragnani, N.; Ferraz, H. M. C.; Silva, G. V. J. Synthesis 1985, 157-183.
9. 9. Lee, K. K.; Rice, G. K.; Hall, I. H.; Amarnath, V. J. Med. Chem. 1987, 30, 586-588.
10. 10. Sanyal, U.; Mitra, S.; Pal, P.; Chakraborti, S. K. J. Med. Chem. 1986, 29, 595-599.
11. 11. Huang, B. R.; Lee, K.H.; Hwang, L. C.; Han, C. H.; Chen, Y. L.; Tzeng, C. C.; Chen, C. F. Chin. Pharm. J. 1991, 43, 447-455.
12. 12. Huang, B. R.; Lee, K.H.; Tseng, T. L.; Wang, H. M.; Chen, C. F.; Tzeng, C. C. Kaohsiung J. Med. Sci. 1993, 22, 2206-2208.
13. 13. Kim, J. C.; Kim, J. A.; Kim, S. H.; Park, J. H.; Kim, S. H.; Choi, S. K.; Park, W. W. Arch. Pharmacol. Res. 1996, 19, 235-239.
14. 14. Kim, J. C.; Kim, J. A.; Park, J. H.; Kim, S. H.; Kim, S. H.; Choi, S. K.; Park, W. W. Arch. Pharmacol Res. 1997, 20, 253-258.
15. 15. Chen, Y. L.; Wang, T. C.; Liang, S. C.; Teng, C. M.; Tzeng, C. C. Chem. Pharm. Bull. 1996, 44, 1591-1595.
16. 16. Chen, Y. L.; Wang, T. C.; Lee, K. H.; Chang Y. L.; Teng, C. M.; Tzeng, C. C. Helv. Chim. Acta 1996, 79, 651-657.
17. 17. Wang, T. C.; Chen, Y. L.; Liou, S. S.; Chang Y. L.; Teng, C. M.; Tzeng, C. C. Helv. Chim. Acta 1996, 79, 1620-1626.
18. 18. Liou, S. S.; Zhao, Y. L.; Chang Y. L.; Teng, C. M.; Tzeng, C. C. Chem. Pharm. Bull. 1997, 45, 1777-1781.
19. 19. Tzeng, C. C.; Wang, T. C.; Chen, Y. L.; Wang, C. J.; Chang Y. L.; Teng, C. M. Helv. Chim. Acta 1997, 80, 1161-1168.
20. 20. Tzeng, C. C.; Zhao, Y. L.; Chen, Y. L.; Liou, S. S.; Wang, T. C.; Chang Y. L.; Teng, C. M. Helv. Chim. Acta 1997, 80, 2337-2344.
21. 21. Monks, A.; Scuderio, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langlay, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. J. Natl. Cancer Inst. 1991, 83, 757-766.
22. 22. Anderson, W. K.; Kasliwal, R.; Houston, D. M.; Wang, Y. S.; Narayanan, V. L.; Haugwitz, R. D.; Plowman, J. J. Med. Chem. 1995, 38, 3789-3797.